Investing.com - Amgen (NASDAQ:AMGN) reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.67 on revenue of $6.71B. Analysts polled by Investing.com anticipated EPS of $4.27 on revenue of $6.67B.
Amgen shares are down 6% from the beginning of the year and are trading at $214.35 , down-from-52-week-high.They are under-performing the Nasdaq which is up 21.43% from the start of the year.
Amgen follows other major Healthcare sector earnings this month
Amgen's report follows an earnings beat by Merck&Co on Thursday, who reported EPS of $1.75 on revenue of $13.15B, compared to forecasts EPS of $1.55 on revenue of $12.32B.
Hoya Corp had beat expectations on Thursday with third quarter EPS of $1.03 on revenue of $1.43B, compared to forecast for EPS of $0.9742 on revenue of $1.42B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar